Skip to main content
NVDA-1.77%AAPL+1.04%GOOGL+0.03%MSFT-0.73%AMZN-0.88%TSM-1.73%SPCX-2.00%META-2.18%AVGO-1.77%TSLA-2.32%LLY+3.82%BRK-B-0.18%SKHY-3.36%MU-0.76%AMD-3.48%WMT+1.59%JPM+0.63%V-0.68%XOM+0.79%ASMLa+2.21%JNJ+1.05%MA-0.30%INTC-2.36%ABBV+3.01%0700.HK-0.42%1398.HK-0.92%CSCO+0.86%CVX+1.02%COST+1.27%KO+0.54%ORCL-7.42%PG+1.09%LRCX-2.42%AMAT-1.63%AP2d+0.82%UNH+2.98%BAC-8.20%DELL-7.18%CAT-0.98%1816.HK+2.71%3988.HK-1.12%0005.HK-1.79%0857.HK+1.17%HSBA.L-1.48%GE+0.68%PM+1.36%0939.HK-1.00%1288.HK-2.23%NFLX-0.30%HD-1.40%USDMXN+1.07%USDSEK+1.02%USDCHF+0.97%USDZAR+0.79%CADCHF+0.75%EURUSD-0.71%AUDCHF+0.69%USDPLN+0.69%USDDKK+0.69%EURHKD-0.67%NZDUSD-0.64%CHFJPY-0.62%EURCNH-0.58%GBPCHF+0.52%USDTHB+0.51%EURCAD-0.50%USDSGD+0.50%NZDCAD-0.45%GBPUSD-0.45%USDNOK+0.44%EURAUD-0.42%GBPTRY+0.41%AUDNZD+0.40%AUDDKK+0.40%NZDMXN+0.39%EURJPY-0.37%PLNJPY-0.36%CHFSEK+0.35%EURSEK+0.34%NZDJPY-0.33%USDJPY+0.33%GBPHKD+0.32%NZDCHF+0.29%GBPMXN-0.28%USDTRY+0.28%AUDUSD-0.27%EURCHF+0.25%EURGBP-0.24%EURNOK-0.23%CHFNOK-0.22%USDCAD+0.22%AUDSGD+0.22%GBPCAD-0.22%GBPNZD+0.19%NZDSGD-0.18%SGDJPY-0.18%EURSGD-0.17%GBPZAR+0.17%GBPAUD-0.17%AUDNOK+0.16%USDILS+0.16%CHFSGD-0.16%GBPJPY-0.13%NOKJPY-0.12%GBPSGD-0.12%EURZAR+0.11%CADJPY+0.10%USDCNH+0.09%AUDJPY+0.05%EURCZK+0.05%AUDCAD-0.05%USDCOP-0.04%EURNZD-0.02%EURPLN+0.01%USDHKD+0.01%EURDKK+0.01%XAGUSD-4.97%GAGUSD-4.96%COFFEE+2.68%XPTUSD-2.56%XNGUSD-2.45%GAUUSD-1.57%XAUUSD-1.57%SUGAR-1.09%COTTON+0.59%COCOA+0.54%S1-0.50%USOIL+0.48%BTCUSD-1.26%ETHUSD+15.24%USDTUSD0.00%XRPUSD+9.86%SOLUSD+10.90%TRXUSDT+1.94%ZECUSDT-2.83%DOGEUSD+11.12%XMRUSDT+0.46%LINKUSD+11.09%XLMUSD-3.45%BCHUSDT-1.32%UNIUSD-4.74%LTCUSD+9.37%SUIUSD-3.19%HBARUSDT-3.32%TONUSD+24.80%TAOUSDT-3.13%AAVEUSD-2.62%DOTUSDT-2.95%ICPUSDT-3.53%ONDOUSDT-4.12%WLDUSDT-5.20%ARBUSDT-5.01%JUPUSDT-4.37%ATOMUSDT-4.85%INJUSDT-3.92%STXUSDT-2.86%FETUSDT-3.27%PYTHUSDT+5.88%TIAUSDT-5.79%SEIUSDT-3.09%IMXUSDT-5.36%OPUSDT-10.56%GRTUSDT-3.67%WIFUSDT-3.70%IOTAUSDT-5.42%AXSUSDT-4.44%POLUSDT-4.81%EOSUSDT+4.19%FARTCOINUSDT-5.61%DYDXUSDT-5.85%GALAUSDT-5.44%ORDIUSDT-4.44%RONINUSDT-7.27%NOTUSDT-5.58%NVDA-1.77%AAPL+1.04%GOOGL+0.03%MSFT-0.73%AMZN-0.88%TSM-1.73%SPCX-2.00%META-2.18%AVGO-1.77%TSLA-2.32%LLY+3.82%BRK-B-0.18%SKHY-3.36%MU-0.76%AMD-3.48%WMT+1.59%JPM+0.63%V-0.68%XOM+0.79%ASMLa+2.21%JNJ+1.05%MA-0.30%INTC-2.36%ABBV+3.01%0700.HK-0.42%1398.HK-0.92%CSCO+0.86%CVX+1.02%COST+1.27%KO+0.54%ORCL-7.42%PG+1.09%LRCX-2.42%AMAT-1.63%AP2d+0.82%UNH+2.98%BAC-8.20%DELL-7.18%CAT-0.98%1816.HK+2.71%3988.HK-1.12%0005.HK-1.79%0857.HK+1.17%HSBA.L-1.48%GE+0.68%PM+1.36%0939.HK-1.00%1288.HK-2.23%NFLX-0.30%HD-1.40%USDMXN+1.07%USDSEK+1.02%USDCHF+0.97%USDZAR+0.79%CADCHF+0.75%EURUSD-0.71%AUDCHF+0.69%USDPLN+0.69%USDDKK+0.69%EURHKD-0.67%NZDUSD-0.64%CHFJPY-0.62%EURCNH-0.58%GBPCHF+0.52%USDTHB+0.51%EURCAD-0.50%USDSGD+0.50%NZDCAD-0.45%GBPUSD-0.45%USDNOK+0.44%EURAUD-0.42%GBPTRY+0.41%AUDNZD+0.40%AUDDKK+0.40%NZDMXN+0.39%EURJPY-0.37%PLNJPY-0.36%CHFSEK+0.35%EURSEK+0.34%NZDJPY-0.33%USDJPY+0.33%GBPHKD+0.32%NZDCHF+0.29%GBPMXN-0.28%USDTRY+0.28%AUDUSD-0.27%EURCHF+0.25%EURGBP-0.24%EURNOK-0.23%CHFNOK-0.22%USDCAD+0.22%AUDSGD+0.22%GBPCAD-0.22%GBPNZD+0.19%NZDSGD-0.18%SGDJPY-0.18%EURSGD-0.17%GBPZAR+0.17%GBPAUD-0.17%AUDNOK+0.16%USDILS+0.16%CHFSGD-0.16%GBPJPY-0.13%NOKJPY-0.12%GBPSGD-0.12%EURZAR+0.11%CADJPY+0.10%USDCNH+0.09%AUDJPY+0.05%EURCZK+0.05%AUDCAD-0.05%USDCOP-0.04%EURNZD-0.02%EURPLN+0.01%USDHKD+0.01%EURDKK+0.01%XAGUSD-4.97%GAGUSD-4.96%COFFEE+2.68%XPTUSD-2.56%XNGUSD-2.45%GAUUSD-1.57%XAUUSD-1.57%SUGAR-1.09%COTTON+0.59%COCOA+0.54%S1-0.50%USOIL+0.48%BTCUSD-1.26%ETHUSD+15.24%USDTUSD0.00%XRPUSD+9.86%SOLUSD+10.90%TRXUSDT+1.94%ZECUSDT-2.83%DOGEUSD+11.12%XMRUSDT+0.46%LINKUSD+11.09%XLMUSD-3.45%BCHUSDT-1.32%UNIUSD-4.74%LTCUSD+9.37%SUIUSD-3.19%HBARUSDT-3.32%TONUSD+24.80%TAOUSDT-3.13%AAVEUSD-2.62%DOTUSDT-2.95%ICPUSDT-3.53%ONDOUSDT-4.12%WLDUSDT-5.20%ARBUSDT-5.01%JUPUSDT-4.37%ATOMUSDT-4.85%INJUSDT-3.92%STXUSDT-2.86%FETUSDT-3.27%PYTHUSDT+5.88%TIAUSDT-5.79%SEIUSDT-3.09%IMXUSDT-5.36%OPUSDT-10.56%GRTUSDT-3.67%WIFUSDT-3.70%IOTAUSDT-5.42%AXSUSDT-4.44%POLUSDT-4.81%EOSUSDT+4.19%FARTCOINUSDT-5.61%DYDXUSDT-5.85%GALAUSDT-5.44%ORDIUSDT-4.44%RONINUSDT-7.27%NOTUSDT-5.58%
IM

Immunovant, Inc. (IMVT)

NASDAQ • Healthcare

$28.71
-$0.76 (-2.6%)
Market open

Last close at October 13, 2026 at 20:00 UTC

Open$29.37
Previous Close$28.71
Day Range$28.7 - $29.64
Avg. Volume (3M)1.6M
Market Cap$5.9B
52 Week Range
$17.02$45.42
Next EarningsIn 26 daysNov 9, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$7M100%
Gross Profitminus cost of goods$7M100%

Fundamentals & Financials

Revenue (TTM)
$7M
Net Income (TTM)
-$538.2M
EPS (TTM)
-$2.82
ROA (TTM)
-63.13%
Current Ratio
7.27

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+15.3%Q1 2026-$0.61
-23.3%Q2 2026-$0.73
-19.3%Q3 2026-$0.75
Next

Nov 9

in 26 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -19.3%

Immunovant’s EPS of -$0.75 trailed the -$0.63 estimate, -19%, while revenue of $7.1 million was in line with the $7.1 million consensus for the first fiscal quarter of 2027, reported on Aug. 6, 2026. Operating income was negative about $153.2 million, and net income was a loss of about $153.2 million, down 27% from a $120.6 million loss a year ago. Next-period consensus calls for EPS of -$0.73 on revenue of $7.1 million.

Next report — what to expect

Immunovant, Inc. (IMVT) reports earnings on November 9, 2026. Wall Street expects EPS of -$0.73 on revenue of $7.1 million. Heading into the release, note that Immunovant has beaten EPS in 3 of 8 most recent quarters, which may frame expectations around any variance versus consensus.

View full earnings history

About Immunovant, Inc.

Immunovant, Inc. is a NASDAQ-listed biotechnology company in the healthcare sector that develops antibody therapies for autoimmune disease. In qualitative terms, it is a clinical-stage business rather than a commercial drug company. The company came public in 2019 and is based in New York City, New York.

Name
Immunovant, Inc.
CEO
Eric Venker
Website
immunovant.com
Industry
Healthcare
Year Founded
2018
Employees
315

Today's Snapshot

AI-generated

IMVT closed 2.6% lower at 28.71. Immunovant held its first-quarter 2027 earnings call.

Trading Volume

Below 10d avg (1.5M)

1.2M

vs S&P 500 Today

Underperforming Market

-2.59%

Updated: October 14, 2026 at 12:32 UTC

Technical Indicators

2 Buy0 Neutral6 Sell
IMVT is in a pronounced downtrend, trading beneath most key moving averages while the MACD and momentum readings remain negative, and the ADX in the low thirties signals a strong directional move to the downside. The RSI and other oscillators are deeply oversold, which reflects selling exhaustion but has not translated into buying strength, and on-balance volume is weak, confirming distribution. Volatility is moderate but has not stemmed the decline, and the pivot sits above the market. Technical takeaway: firm bearish trend; the technical bias is strongly negative.
All signals
  • EMA (5 indicators)$31.35 - $35.87
    Sell
  • RSI (14)16.65
    Buy
  • Stochastic %K (14, 3, 3)6.69
    Buy
  • MACD Level (12, 26)-2.33
    Sell

Peers & Related Assets

TGTXTG Therapeutics, Inc.
$54.34-1.7%
ZBIOZenas BioPharma, Inc.
$25.16-4.7%
ANABAnaptysBio, Inc.
$45.59-1.0%
TRAXFirst Tracks Biotherapeutics Inc
$31.68-7.0%
CGEMCullinan Therapeutics, Inc.
$14.1-5.7%
ANNXAnnexon, Inc.
$3.83-3.3%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.